MYO1C and endometrial carcinoma: Pairwise differences between sample groups were not significant; however, when the MYO1C protein level pattern in all tumors as a group (n = 62) were compared with hyperplasia samples (n = 10), the Fisher’s exact test analysis showed a statistically significant association (P = 0.0303) between groups of samples and levels of MYO1C (Fig 2C), indicating that the amount of MYO1C protein was significantly lower in endometrial carcinomas compared to hyperplasia.